Immunophenotypic shifts during minimal residual evaluation in a case of leukemic form of anaplastic large cell lymphoma ALK.

Maria Clara CanellasEnrico Bruno-RiscarolliCristiane S Ferreira-FacioDaiana V Lopes-AlvesVitor D BotafogoDeborah SutterRoberia M PontesMarcelo G P LandCristiane Bedran MilitoElaine Sobral da Costa

Published in: Cancer reports (Hoboken, N.J.) (2021)

MFC can be a useful tool for ALCL diagnosis and MRD monitoring and may support therapeutic decisions.

Keyphrases

single cell
diffuse large b cell lymphoma
acute myeloid leukemia
cell therapy
stem cells
tyrosine kinase